通过转化治疗方法增强核类模拟反应,以克服抗性
Jenna Thibodeau1, Kian Hershberger1,2, Sai Samanvitha M Ramakrishna1
1Cancer Biology Graduate Program, Wayne State University School of Medicine, Detroit, MI 48201, USA.
核糖类相似物是重要的癌症药物,但耐药性限制了它们的有效性. 了解和克服这些疗法的生物障碍,使用小分子,可以改善癌症治疗结果.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学 是一个学科.
- 分子生物学分子生物学
背景情况:
- 核酸类类似物在治疗血液性恶性瘤和固体瘤方面至关重要.
- 对核糖类类似物的治疗耐药性往往导致癌症复发和死亡率.
研究的目的:
- 审查核酸类比电阻的机制.
- 突出克服耐药性和提高治疗疗效的策略.
主要方法:
- 文献综述 整合了近期关于核类模拟耐药性的进展.
- 对影响核类模拟活性的生物学障碍的分析.
- 探索针对抗性机制的小分子抑制剂.
主要成果:
- 抵抗源于多种生物障碍:细胞吸收,细胞内激活,核酸池平衡,基因组监测和线粒体压力.
- 每个级别的变化都对治疗失败有很大影响.
- 小分子抑制剂可以利用这些漏洞来增强核类模拟的疗效.
结论:
- 开发小分子抑制剂对于克服核类模拟耐药性至关重要.
- 针对抗性机制的组合疗法可以改善患者的治疗结果.
- 恢复亡能力是增强基于核糖类模拟的癌症疗法的关键.
更多相关视频
08:46Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides
Published on: July 26, 2018
07:20A Novel Approach to Overcome Movement Artifact When Using a Laser Speckle Contrast Imaging System for Alternating Speeds of Blood Microcirculation
Published on: August 30, 2017
相关概念视频
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Termination of Translation
Improving Translational Accuracy
